FILE PHOTO: The company logo for pharmaceutical company AstraZeneca is displayed on a screen on the floor at the New York Stock Exchange in New York, U.S., April 8, 2019. REUTERS/Brendan McDermid/File Photosaid on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be incurred by the British drugmaker.
“To cover these additional expenses, the company will add an amount equivalent to a maximum of 20% of the manufacturing costs to ensure there is no material impact on its finances this year while continuing efforts to provide the vaccine at no profit during the pandemic,” the statement added. These agreements are with companies and governments as the company gets closer to reporting early results of a late-stage clinical trial. Developed by the University of Oxford and licensed to AstraZeneca in April, the vaccine is expected to be one of the first from big pharma to secure regulatory approval.
blaireerskine your daughter is doing what?
The idea of equitable often means different things to different people/companies. It often defers to the legal meaning.
Really? Reuters has ZERO interest in the JOE Biden crime scandals? THE biggest NEWS in the history of presidential races? HOW MUCH ARE THEY PAYING YOU?
We have summarized this news so that you can read it quickly. If you are interested in the news, you can read the full text here. Read more:
United States Latest News, United States Headlines
Similar News:You can also read news stories similar to this one that we have collected from other news sources.
AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costsAstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be incurred by the British drugmaker. 'AstraZeneca has also been granted protection from future liability claims.' 😮😮😮. So much love for the poor people, eh? Disgusting!! at least we know we wont die in vain executives will get their bonus
Source: Reuters - 🏆 2. / 97 Read more »
AstraZeneca, Oxford coronavirus vaccine trial can continue in the US - Business InsiderBusiness Insider is a fast-growing business site with deep financial, media, tech, and other industry verticals. Launched in 2007, the site is now the largest business news site on the web.
Source: BusinessInsider - 🏆 729. / 51 Read more »
WSJ News Exclusive | Covid-19 Vaccine Trial From AstraZeneca, Oxford Can Resume in U.S.Covid-19 vaccine trial From AstraZeneca PLC and the University of Oxford can resume in U.S., according to a person familiar with the matter. So who wants to die next? ‘According the the person familiar with the matter ‘...alright then. Convenient pump
Source: WSJ - 🏆 98. / 63 Read more »
AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJFederal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter. I think this is the one I don't want to try? WTF! Never try this vaccine, which may be 10 times dangerous than CCP virus itself. Stock price more important?
Source: Reuters - 🏆 2. / 97 Read more »
AstraZeneca says its Oxford vaccine deal allows it to add up to 20% of manufacturing costsAstraZeneca Plc said on Friday its coronavirus vaccine deal with Oxford University will allow it to add up to 20% of manufacturing costs to cover additional expenses required to be incurred by the British drugmaker. 'AstraZeneca has also been granted protection from future liability claims.' 😮😮😮. So much love for the poor people, eh? Disgusting!! at least we know we wont die in vain executives will get their bonus
Source: Reuters - 🏆 2. / 97 Read more »
AstraZeneca, Oxford allowed to resume COVID-19 vaccine trial in U.S. - WSJFederal health regulators have decided to allow the resumption of U.S. studies of a leading COVID-19 vaccine candidate from AstraZeneca Plc and the University of Oxford, the Wall Street Journal reported on Friday, citing people familiar with the matter. I think this is the one I don't want to try? WTF! Never try this vaccine, which may be 10 times dangerous than CCP virus itself. Stock price more important?
Source: Reuters - 🏆 2. / 97 Read more »